Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Autoimmune Disorders

Free Subscription 22.12.2025 1 BMC Neurol 5 Diabetes 3 Intern Med 2 J Autoimmun 3 J Clin Endocrinol Metab 1 J Neuroimmunol 4 J Neurol 2 J Rheumatol 1 Mult Scler 3 Neurology 1 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. GLAUBITZ S, Meyer S, Loris J, Zeng R, et al
   Physical activity and its effects in myasthenia gravis: a patient-reported study on habits and impact.
   BMC Neurol. 2025 Dec 17. doi: 10.1186/s12883-025-04590.
   PubMed         Abstract available
   
   

   
   Diabetes

2. DEUTSCH AJ, Bell AS, Michalek DA, Burkholder AB, et al
   Development and Validation of a Type 1 Diabetes Multi-Ancestry Polygenic Score.
   Diabetes. 2025 Nov 14:db250772. doi: 10.2337/db25-0772.
   PubMed         Abstract available
   
   
3. OSHIMA M, Halliez C, Kobaisi F, Mode N, et al
   Killing of Human beta-Cells by CD8+ T Cells Triggers Inflammatory Paracrine Signaling and Neighboring beta-Cell Dysfunction.
   Diabetes. 2026;75:124-132.
   PubMed         Abstract available
   
   
4. OROZCO S, Aljobaily N, Reynolds HM, Oceguera GA, et al
   Flt3L-Derived Antigen-Presenting Cell Transfer in Neonatal NOD Mice Reduces the Incidence of Type 1 Diabetes.
   Diabetes. 2025 Nov 6:db250055. doi: 10.2337/db25-0055.
   PubMed         Abstract available
   
   
5. GONCALVES LM, Shirvaikar I, Sideris K, Pereira E, et al
   Microvascular Homeostasis Is Compromised in Pancreatic Islets in a Mouse Model of beta-Cell Loss and Low-Grade Inflammation.
   Diabetes. 2026;75:70-84.
   PubMed         Abstract available
   
   
6. GROEGLER J, Mangold K, Nicholson K, Dang M, et al
   Strategic Reduction of Hybrid Insulin Peptide Formation Significantly Delays Diabetes Onset in NOD Mice.
   Diabetes. 2025 Oct 21:db250324. doi: 10.2337/db25-0324.
   PubMed         Abstract available
   
   

   
   Intern Med

7. ITOH K, Otsuki N, Suzuki Y, Kiriba C, et al
   Successful Reswitching of Thrombopoietin Receptor Agonists: Two Cases of Immune Thrombocytopenia and Severe Aplastic Anemia.
   Intern Med. 2025;64:3553-3556.
   PubMed         Abstract available
   
   
8. HATANAKA Y, Mori-Yoshimura M, Utsugisawa K, Tsujino A, et al
   Long-term Efficacy and Safety of Amifampridine Phosphate (Firdapse((R))) in Japanese Patients with Lambert-Eaton Myasthenic Syndrome (LMS-005 Study).
   Intern Med. 2025;64:3493-3501.
   PubMed         Abstract available
   
   
9. ISHII N, Miyamoto M
   Autonomic Dysfunction in Miller Fisher Syndrome: Paralytic Ileus and Isolated Internal Ophthalmoplegia.
   Intern Med. 2025;64:3560-3563.
   PubMed         Abstract available
   
   

   
   J Autoimmun

10. TIAN T, Rao L, Wei M, Du J, et al
    Circadian clock genes: Potential therapeutic targets for autoimmune diseases.
    J Autoimmun. 2025;158:103516.
    PubMed         Abstract available
    
    
11. SOUSA CDF, Terroba-Navajas P, Tzartos J, Oreskovic ID, et al
    Humoral correlates of clinical response to thymectomy in myasthenia gravis.
    J Autoimmun. 2025;158:103517.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

12. JING G, Tang J, Li Y, Li Y, et al
    Thyrotrophin receptor antibody: objective and quantitative inflammatory indicator in patients with thyroid eye disease.
    J Clin Endocrinol Metab. 2025 May 9:dgaf273. doi: 10.1210.
    PubMed         Abstract available
    
    
13. MUNOZ-PARDEZA J, Gracia-Marco L, Lopez-Gil JF, Hormazabal-Aguayo I, et al
    The role of muscular fitness on bone mineral content and areal bone mineral density in youth with type 1 diabetes.
    J Clin Endocrinol Metab. 2025 Jun 5:dgaf328. doi: 10.1210.
    PubMed         Abstract available
    
    
14. HEDBERG F, Lindh JD, Mannheimer B, Planck T, et al
    Influence of Preexisting Psychiatric Morbidity on Liothyronine Use in Hypothyroidism: A Swedish Nationwide Cohort Study.
    J Clin Endocrinol Metab. 2025 Jun 7:dgaf337. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

15. ULUC F, Ceylan D, Turkoglu SA
    Pilot analysis of Chitinase-3-like protein 1 and soluble Syndecan-1 CSF levels as potential biomarkers in relapsing-remitting multiple sclerosis.
    J Neuroimmunol. 2025;411:578836.
    PubMed         Abstract available
    
    

    
    J Neurol

16. KONITSIOTI AM, Schweitzer F, Johannis W, Steffen F, et al
    Serum neurofilament light chain as a biomarker of disease control in multiple sclerosis: a real-world cross-sectional analysis of therapeutic regimens.
    J Neurol. 2025;273:34.
    PubMed         Abstract available
    
    
17. LU C, Lin Y, Wu M, Chen J, et al
    Brain atrophy in autoimmune encephalitis: epidemiology, pathophysiology, clinical manifestations, treatment, and prognosis-an update.
    J Neurol. 2025;273:32.
    PubMed         Abstract available
    
    
18. CABON J, Ducloie M, Chretien B, Arnaud C, et al
    Guillain-Barre syndrome associated with immune checkpoint inhibitors exposure: a pharmacovigilance study.
    J Neurol. 2025;273:27.
    PubMed         Abstract available
    
    
19. TAN H, Yin Z, Zhangbao J, Li X, et al
    Retinal nerve fiber layer thinning in multiple sclerosis: clinical implications, cognitive associations, and effects of disease-modifying therapies.
    J Neurol. 2025;273:25.
    PubMed         Abstract available
    
    

    
    J Rheumatol

20. QIAO J, Ma Y, Zhang X, Zhu G, et al
    Evaluating the Applicability of the EULAR/ACR-2019, SLICC-2012, and ACR-1997 Classification Criteria for Systemic Lupus Erythematosus in Children: a multicenter study.
    J Rheumatol. 2025 Dec 15:jrheum.2025-0559. doi: 10.3899/jrheum.2025-0559.
    PubMed         Abstract available
    
    
21. BENSON KRK, Becerril A, Park J, Plantinga L, et al
    The Impact of Everyday Discrimination on Systemic Lupus Erythematous Disease Activity and Mental Health Outcomes.
    J Rheumatol. 2025 Dec 15:jrheum.2025-0631. doi: 10.3899/jrheum.2025-0631.
    PubMed         Abstract available
    
    

    
    Mult Scler

22. RATTI S, Eke H, Cantarutti A, Bonn SE, et al
    Mediterranean diet and risk of multiple sclerosis: A prospective cohort study.
    Mult Scler. 2025 Dec 15:13524585251396408. doi: 10.1177/13524585251396408.
    PubMed         Abstract available
    
    

    
    Neurology

23. BOS L, Wink AM, Cole JH, Strijbis EMM, et al
    Association of Brain Age With Physical Disability and Cognitive Impairment in People With Multiple Sclerosis of the Same Age.
    Neurology. 2026;106:e214527.
    PubMed         Abstract available
    
    
24. SPAIN RI, Paz Soldan MM, Freedman MS, Repovic P, et al
    Lipoic Acid for Treatment of Progressive Multiple Sclerosis: A Phase 2 Randomized Clinical Trial.
    Neurology. 2026;106:e214454.
    PubMed         Abstract available
    
    
25. BRIGGS FBS, Amezcua L
    Alpha Lipoic Acid in Multiple Sclerosis: It's All in the Details.
    Neurology. 2026;106:e214578.
    PubMed        
    
    

    
    PLoS One

26. VAUTHIER JC, Choley L, Kabuth B
    Chronic illness and extreme performance: Type 1 diabetes in ultra-endurance.
    PLoS One. 2025;20:e0338637.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

27. TAGHIPOUR-MIRAKMAHALEH R, Morin F, Zhang Y, Bourhoven L, et al
    Turncoat antibodies unmasked in a model of autoimmune demyelination: From biology to therapy.
    Proc Natl Acad Sci U S A. 2025;122:e2424988122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.